IBUPROFEN SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Ibuprofen Sodium patents expire, and what generic alternatives are available?
Ibuprofen Sodium is a drug marketed by Perrigo R And D and is included in one NDA.
The generic ingredient in IBUPROFEN SODIUM is ibuprofen sodium. There are sixty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ibuprofen sodium profile page.
Summary for IBUPROFEN SODIUM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 45 |
Clinical Trials: | 37 |
Patent Applications: | 410 |
Formulation / Manufacturing: | see details |
DailyMed Link: | IBUPROFEN SODIUM at DailyMed |
Recent Clinical Trials for IBUPROFEN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cairo University | Early Phase 1 |
Region Hovedstadens Apotek | Phase 3 |
Herlev and Gentofte Hospital | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for IBUPROFEN SODIUM
US Patents and Regulatory Information for IBUPROFEN SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Perrigo R And D | IBUPROFEN SODIUM | ibuprofen sodium | TABLET;ORAL | 206581-001 | Aug 3, 2015 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |